Skip to main content
. 2018 Jun 18;8(3):425–433. doi: 10.1007/s13555-018-0247-0

Table 2.

Percentage reduction in AK count since baseline, complete clearance, and absolute reduction in AK count since baseline

Number of baseline AKs N Mean percentage reduction at week 8a Mean complete clearance at week 8a Mean difference in AK count at week 8a
4–8 baseline AKs 532 74.3 40.9 4.7
9–12 baseline AKs 245 70.2 22.3 7.3
13–20 baseline AKs 311 73.9 14.8 12.2

AKs Actinic keratoses

aData presented in table are pooled data from Studies 1–6, ingenol mebutate treatment groups